Therapeutic area intelligence for Local Anesthetics with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Dexamethasone →

Medline →

Recent signals(3)

StrategyAugust 4, 2026

Medline Issues Correction for Convenience Kits Containing Recalled Lidocaine and Bupivacaine

Medline is removing recalled Lidocaine Hydrochloride and Bupivacaine Hydrochloride from convenience kits.

ClinicalJuly 22, 2026

Trial Comparing Liposomal Bupivacaine and Dexamethasone for Postoperative Pain Control

A trial is set to compare liposomal bupivacaine plus plain bupivacaine against dexamethasone plus plain bupivacaine in patients at risk for severe postoperative pain.

StrategyJune 22, 2026

Medline Issues Correction for Bupivacaine Hydrochloride Kits

Medline is recalling convenience kits that contain Huons Bupivacaine Hydrochloride in Dextrose Injection due to safety concerns.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.